Efficacy and safety of pimecrolimus cream 1% in infants: A combined analysis of a clinical program in 923 patients

被引：0
|
作者：
Paul, C
Rossi, AB
Cork, M
de Prost, Y
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Univ Sheffield, Sch Med, Sheffield, S Yorkshire, England
[3] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England
[4] Hop Necker Enfants Malad, Paris, France
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：P69 / P69
页数：1
相关论文
共 50 条
  • [21] Treatment with pimecrolimus cream 1% is corticosteroid sparing in infants with atopic dermatitis
    Kapp, A
    Papp, K
    Gulliver, W
    Goertz, HP
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 350 - 350
  • [22] Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children
    Wahn, U
    Bos, JD
    Goodfield, M
    Caputo, R
    Papp, K
    Manjra, A
    Dobozy, A
    Paul, C
    Molloy, S
    Hultsch, T
    Graeber, M
    Cherill, R
    de Prost, Y
    PEDIATRICS, 2002, 110 (01) : e2
  • [23] Safety and Efficacy of Tacrolimus Ointment Versus Pimecrolimus Cream in the Treatment of Patients with Atopic Dermatitis Previously Treated with Corticosteroids
    Kirsner, Robert S.
    Heffernan, Michael P.
    Antaya, Richard
    ACTA DERMATO-VENEREOLOGICA, 2010, 90 (01) : 58 - 64
  • [24] Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents
    Eichenfield, LF
    Lucky, AW
    Boguniewicz, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (04) : 495 - 504
  • [25] A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial
    Koca, R.
    Altinyazar, H. C.
    Ankarali, H.
    Muhtar, S.
    Tekin, N. S.
    Cinar, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (03) : 251 - 256
  • [26] An update on the safety and tolerability of pimecrolimus cream 1%: Evidence from clinical trials and post-marketing surveillance
    Langley, Richard G. B.
    Luger, Thomas A.
    Cork, Michael J.
    Schneider, Dirk
    Paul, Carle
    DERMATOLOGY, 2007, 215 : 27 - 44
  • [27] The Efficacy of Pimecrolimus 1% Cream Combined with Microdermabrasion in the Treatment of Nonsegmental Childhood Vitiligo: A Randomized Placebo-Controlled Study
    Farajzadeh, Saeedeh
    Daraei, Zahra
    Esfandiarpour, Iraj
    Hosseini, Seyed Hamed
    PEDIATRIC DERMATOLOGY, 2009, 26 (03) : 286 - 291
  • [28] A retrospective analysis of pimecrolimus cream 1% for treatment of facial vitiligo
    Mayoral, FA
    Vega, JM
    Stavisky, H
    McCormick, CL
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB194 - AB194
  • [29] Efficacy of pimecrolimus cream versus placebo in chronic car eczema: A randomized clinical trial
    Bjerke, JR
    Haug, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB93 - AB93
  • [30] An exploratory study to determine the efficacy of 1% pimecrolimus cream in the treatment of pityriasis alba
    Fujita, W
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P46 - P46
12345